CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | -33.3% | 750 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 750 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -20.0% | 750 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | +25.0% | 750 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 750 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | 0.0% | 750 | +25.0% | 0.00% | -100.0% |
| Q1 2020 | $4,000 | -33.3% | 600 | +9.1% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | +200.0% | 550 | +539.5% | 0.00% | – |
| Q4 2018 | $2,000 | -66.7% | 86 | -57.0% | 0.00% | -100.0% |
| Q3 2018 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |